aripiprazole has been researched along with Mood Disorders in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (45.83) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| DelBello, MP; Jallaq, SA; Martin, LJ; Ramsey, LB; Strawn, JR; Verba, M | 1 |
| Binici, NC; Güney, SA | 1 |
| Bota, RG; Hazen, J; Howard, P; Nguyen, C; Novac, A; Tieu, R | 1 |
| Gunes, S | 1 |
| Bartram, LA; Coury, DL; Lozano, J | 1 |
| Camkurt, MA; Gunes, S; Tecimer, E | 1 |
| Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M | 1 |
| Bengtson, M; Edge, PJ; Murphy, TK; Mutch, PJ; Reid, JM; Storch, EA; Yang, M | 1 |
| Agüera-Ortiz, L; Hurtado de Mendoza, A; Osorio, RS; Palomo, T; Ramos, I | 1 |
| Wagner, KD | 1 |
| McIntyre, RS | 2 |
| Aleman, A; Bous, J; Hollander, K; Knegtering, H; Liemburg, E | 1 |
| Kurokawa, K; Ohkuma, S; Shibasaki, M | 1 |
| Ahn, ES; Pidcock, FS; Sanz, JH; Slomine, BS; Wachtel, LE; Yap, JL | 1 |
| Coffey, DB; John, N; Potter, PO | 1 |
| Sajatovic, M | 1 |
| Buckley, PF | 1 |
| Demb, H; Valicenti-McDermott, MR | 1 |
| García-Amador, M; Goikolea, JM; Pacchiarotti, I; Sanchez, RF; Valentí, M; Vieta, E | 1 |
| Modestin, J; Schneiter, R; Traber, R | 1 |
| Rai, A; Spiegel, D; Urbano, M | 1 |
| Carlson, BX; Eudicone, J; Frye, MA; Marcus, RN; McQuade, RD; Pikalov, A | 1 |
| Stahl, SM | 1 |
5 review(s) available for aripiprazole and Mood Disorders
| Article | Year |
|---|---|
Aripiprazole for treating irritability associated with autism spectrum disorders.
Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Communication; Humans; Irritable Mood; Mood Disorders; Treatment Outcome | 2019 |
[Functional homology between alcohol dependence and mood disorder].
Topics: Alcoholism; Animals; Antipsychotic Agents; Aripiprazole; Hypothalamo-Hypophyseal System; Mice; Mood Disorders; Piperazines; Pituitary-Adrenal System; Quinolones; Receptors, Serotonin; Serotonin Plasma Membrane Transport Proteins | 2011 |
Treatment for mood and anxiety disorders: quetiapine and aripiprazole.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Dibenzothiazepines; Humans; Mood Disorders; Piperazines; Quetiapine Fumarate; Quinolones | 2003 |
Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Mood Disorders; Piperazines; Quinolones; Schizophrenia | 2005 |
Role of aripiprazole in treating mood disorders.
Topics: Administration, Oral; Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Drug Administration Schedule; Humans; Mood Disorders; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinolones; Treatment Outcome | 2006 |
2 trial(s) available for aripiprazole and Mood Disorders
| Article | Year |
|---|---|
Open label aripiprazole in the treatment of youth with tic disorders.
Topics: Adolescent; Age Factors; Aripiprazole; Child; Female; Humans; Male; Mood Disorders; Piperazines; Quinolones; Tic Disorders; Treatment Outcome | 2009 |
An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Mood Disorders; Personal Satisfaction; Pilot Projects; Piperazines; Pleasure; Quinolones; Risperidone; Schizophrenia | 2011 |
17 other study(ies) available for aripiprazole and Mood Disorders
| Article | Year |
|---|---|
CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Male; Mood Disorders; Pharmacogenetics; Phenotype; Retrospective Studies | 2021 |
Epistaxis as an Unexpected Side Effect of Aripiprazole and Risperidone Treatment in Two Children with Two Different Psychiatric Diagnosis.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Epistaxis; Humans; Male; Mood Disorders; Risperidone | 2017 |
Weight gain changes in patients with aripiprazole monotherapy compared with aripiprazole-antidepressant polypharmacy in an outpatient sample.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Body Mass Index; Cohort Studies; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Outpatients; Polypharmacy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Weight Gain | 2018 |
Hyperprolactinemic Galactorrhea as a Side Effect of Aripiprazole: An Adolescent Case (Aripiprazole-Related Hyperprolactinemic Galactorrhea).
Topics: Adolescent; Adolescent Behavior; Antipsychotic Agents; Aripiprazole; Female; Galactorrhea; Humans; Hyperprolactinemia; Mood Disorders | 2018 |
Aripiprazole-Induced Raynaud's Phenomenon: An Adolescent Case.
Topics: Adolescent; Aripiprazole; Humans; Male; Mood Disorders; Raynaud Disease | 2016 |
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Treatment of tardive dyskinesia with aripiprazole.
Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Mood Disorders; Piperazines; Quinolones | 2010 |
Life events, medical comorbidity, and somatic symptoms in pediatric mood disorders.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Comorbidity; Female; Humans; Hungary; Life Change Events; Male; Mood Disorders; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Somatoform Disorders; United States | 2009 |
The role of aripiprazole in Canada: A review of clinical and drug discontinuation data. Foreword.
Topics: Antipsychotic Agents; Aripiprazole; Canada; Clinical Trials as Topic; Comorbidity; Drug Utilization; Drug Utilization Review; Humans; Metabolic Diseases; Mood Disorders; Piperazines; Psychotic Disorders; Quinolones; Risk Factors | 2010 |
Aripiprazole: striving towards euthymia with a novel mechanism of action.
Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Humans; Mood Disorders; Piperazines; Quinolones | 2011 |
Treatment of cerebellar cognitive affective syndrome with aripiprazole.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Cerebellar Diseases; Cognition Disorders; Female; Humans; Infratentorial Neoplasms; Mood Disorders; Neurosurgical Procedures; Papilloma, Choroid Plexus; Piperazines; Postoperative Complications; Quinolones; Syndrome | 2012 |
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment | 2012 |
Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Mass Index; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Drug Approval; Female; Follow-Up Studies; Humans; Impulsive Behavior; Intellectual Disability; Male; Mood Disorders; Piperazines; Quinolones; Reactive Attachment Disorder; Self-Injurious Behavior; Sleep Wake Disorders | 2006 |
A case of aripiprazole-induced mania.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dibenzothiazepines; Humans; Male; Mood Disorders; Piperazines; Quetiapine Fumarate; Quinolones; Schizophrenia, Paranoid | 2007 |
Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Mood Disorders; Piperazines; Quinolones; Risperidone; Withholding Treatment | 2007 |
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials.
Topics: Affective Symptoms; Aggression; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Humans; Irritable Mood; Mood Disorders; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Do dopamine partial agonists have partial efficacy as antipsychotics?
Topics: Antipsychotic Agents; Aripiprazole; Brain; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Mood Disorders; Piperazines; Psychotic Disorders; Quinolones; Receptors, Dopamine D2; Treatment Outcome | 2008 |